Results of Treatment with Pollen Extract (Cernilton) in Chronic Prostatitis and Prostatodynia

Rugendorff, E.W., W. Weidner, L. Ebling, and A.C. Buck.
"Results of Treatment with Pollen Extract (Cernilton) in Chronic Prostatitis and Prostatodynia."
British Journal of Urology

Abstract
Department of Urology, Georg-August-University, Göttingen, Germany.

We report the results of a prospective study with the pollen extract, Cernilton N, in a dose of 1 tablet tid for 6 months for the treatment of chronic prostatitis syndrome in 90 patients. The factors documented before and after 3 and 6 months' treatment were digital rectal examination (DRE) of the prostate, uroflowmetry, bacterial studies, leucocyte counts in urine and measurement of complement C3/coeruloplasmin in the seminal fluid. The patients were divided into 2 groups: those without associated complicating factors (CFs) (n = 72) and those with complicating factors, i.e. urethral strictures, prostatic calculi, bladder neck sclerosis (n = 18). In the group without CFs, 56 (78%) had a favorable response; 26 (36%) were cured of their symptoms and signs and 30 (42%) improved significantly with an increase in flow rate, a reduction in leukocyturia in the post-prostate massage urine (VB3) and a decrease in complement C3/coeruloplasmin in the ejaculate. In the patients with CFs only 1 patient showed a response. Complicating factors should be considered in patients who fail to respond to treatment within 3 months. Cernilton N was well tolerated by 97% of patients.

To retrieve the full report go to: http://www.ncbi.nlm.nih.gov/pubmed/8499988